ANTHELCIDE EQ DIN 01904787
Status: Cancelled Post Market
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | OXIBENDAZOLE 5.45 G |
|---|
| Dosage form | Paste |
|---|
| Route | Oral |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1991 |
|---|
| Current status date | 26-Jul-2016 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXIBENDAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00579394 | ANTHELCIDE EO PASTE 22.7% | NORDEN LABORATORIES INC. | Paste | OXIBENDAZOLE 22.7 % | Cancelled Post Market |
| 00577332 | ANTHELCIDE EQ SUS | NORDEN LABORATORIES INC. | Suspension | OXIBENDAZOLE 10 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 15282 | 2014-02-14 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 6528 | 1999-05-04 | New Drug Submission (NDS) | |
Request a quote for ANTHELCIDE EQ
How to read a Canadian DIN record